Abstract
Results of experience with a low-oestrogen combined contraceptive in 1,085 women showed that a dosage of less than 50 μg is compatible with satisfactory cycle control and efficacy. The preparation used in the trial, which contained 0·5 mg dl-norgestrel and 0·03 mg ethinyloestradiol, proved acceptable to most of the women.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Goldzieher J. W., Moses L. E., Averkin E., Scheel C., Taber B. Z. A placebo-controlled double-blind crossover investigation of the side effects attributed to oral contraceptives. Fertil Steril. 1971 Sep;22(9):609–623. [PubMed] [Google Scholar]
- Hallberg L., Högdahl A. M., Nilsson L., Rybo G. Menstrual blood loss--a population study. Variation at different ages and attempts to define normality. Acta Obstet Gynecol Scand. 1966;45(3):320–351. doi: 10.3109/00016346609158455. [DOI] [PubMed] [Google Scholar]